![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 25, 16985-16990, June 23, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
in the Inhibition of Tumor Necrosis Factor-
- and Interleukin-1
-induced Inflammatory Gene Expression*
1



From the
Reddy US Therapeutics, Dr. Reddy's Laboratories, Norcross, Georgia 30071 and
Department of Medicine, Columbia University, New York, New York 10032
Glycogen synthase kinase-3
(GSK-3
) is a serine/threonine kinase with a broad array of cellular targets, such as cytoskeletal proteins and transcription factors. Recent studies with GSK-3
-null mice showed impaired NF
B-mediated survival responses. Because NF
B serves a dual role as a key regulator of cytokine-induced inflammatory gene expression and apoptosis, we investigated whether modulation of GSK-3
expression affects cytokine-induced and NF
B-mediated inflammatory gene expression. We observed that tumor necrosis factor-
(TNF-
) and interleukin-1
(IL-1
) treatment of primary cultures of human microvascular cells reduced net endogenous active GSK-3
protein levels while inducing inflammatory cytokine (IL-6 and monocyte chemoattractant protein-1 (MCP-1)) expression. Interestingly, inhibition of GSK-3
by antisense oligonucleotides or pharmacological agent (10 mM lithium) potentiated TNF-induced expression of IL-6 and MCP-1 by 26-fold suggesting that inhibition of GSK-3
under inflammatory conditions (exposure to TNF-
and IL-1
) may contribute to enhanced cytokine expression. Overexpression of GSK-3
in endothelial cells, in contrast, significantly inhibited (by 70%, p < 0.01) both TNF-
and IL-1
-induced expression of IL-6, MCP-1, and vascular cell adhesion molecule-1. Using adenoviruses in lipopolysaccharide-stimulated mice, overexpression of GSK-3
significantly decreased TNF-
expression in lung and heart tissues (38 and 15%, respectively), further confirming the anti-inflammatory role of GSK-3
. Overexpression of GSK-3
did not affect the TNF-
-induced nuclear translocation of NF
B but reduced the nuclear half-life of TNF-
-induced NF
B considerably (by as much as 9 h) and enhanced phosphorylation (by as much as 33%). Interestingly, neither endothelial cell survival nor NF
B-mediated expression of anti-apoptotic genes was affected by GSK-3
overexpression. We conclude that GSK-3
selectively regulates NF
B-mediated inflammatory gene expression by controlling the flow of NF
B activity between transcription of inflammatory and survival genes.
Received for publication, March 15, 2006
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Table 1.
1 To whom correspondence should be addressed: Reddy US Therapeutics, Dr. Reddy's Laboratories, 3065 Northwoods Circle, Norcross, GA 30071. Tel.: 770-446-9500; Fax: 770-446-1950; E-mail: avines{at}reddyus.com.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. J. Wiles, B. K. Dhakal, D. S. Eto, and M. A. Mulvey Inactivation of Host Akt/Protein Kinase B Signaling by Bacterial Pore-forming Toxins Mol. Biol. Cell, April 1, 2008; 19(4): 1427 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Wang, S.-Z. Lin, J.-S. Kuo, H.-Y. Huang, S.-F. Tzeng, C.-H. Liao, D.-C. Chen, and W.-F. Chen Urocortin Modulates Inflammatory Response and Neurotoxicity Induced by Microglial Activation J. Immunol., November 1, 2007; 179(9): 6204 - 6214. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |